logo logo-mobile

  • Home
  • Product
    • FDF
    • API
  • About Us
    • Profiles
    • Video
    • Honor
  • News
  • Contact Us

中/EN

logo logo-mobile

  • Home
  • Product
    • FDF
    • API
  • About Us
    • Profiles
    • Video
    • Honor
  • News
  • Contact Us
  • 展会邀请函
    Wanhan Pharma | Welcome to CIHF China(GuangZhou)2025 (Booth: H6-B08)
  • 展会邀请函
    WanHan Pharma丨Welcome to CPHI China(ShenZhen)2025 (Booth: 9J31)
  • 画板 1
    WANHAN PHARMACEUTICAL COMPANY丨API Crisaborole has been successfully authorized.
  • 布美他尼注射液
    WANHAN PHARMACEUTICAL COMPANY | Bumetanide Injection has been officially approved
  • 联苯苄唑喜报
    WANHAN PHARMACEUTICAL COMPANY丨API Bifonazole has been successfully authorized.
  • 精氨酸布洛芬颗粒
    WANHAN PHARMACEUTICAL COMPANY | Ibuprofen Arginine Granules has been officially approved
  • 法莫替丁注射液
    WANHAN PHARMACEUTICAL COMPANY丨Famotidine Injection has been officially approved
  • 参会邀请(邮件)_画板 1
    Wanhan Pharma丨Welcome to visit CPHI South East Asia
  • 1
  • 2
  • 3
  • 4
  • 7

Contact Us

Foreign Trade (API, FDF)

 

Mob:

+86 139 - 2498 - 2439(WeChat&WhatsApp)

+86 199 - 2800 - 9162(WhatsApp)

+86 199 - 6631 - 1970(WhatsApp)

 

E-mail:

Foreign-Trade@whpt.com.cn 

Copyright @ 2023: Zhongshan Wanhan Pharmaceutical Co., Ltd.